Iacob Mathiesen

[Iacob Mathiesen @iacob66]

@hasantoxr Norway

[Ed Yong is not here @edyong209]

🛑I wrote about what “fatigue” really means for people with long COVID and ME/CFS, and why this profoundly debilitating symptom is so often misunderstood and trivialized.

(This piece also covers PEM.) 1/

https://t.co/oFWb6Flyh0

[Iacob Mathiesen @iacob66]

@JonLaake @AakreMoberg Det hadde vært interessant å vite hvem som har gjort disse studiene, er det industrien?

[Iacob Mathiesen @iacob66]

@akbefring Hvordan kan det gjøres enklere å gjennomføre klinisk forsking. Intensjonen for klinisk forskning er i utgangspunktet god men ting kan gå galt, noen kan ha uredelig intensjoner, personvern kan bli krenket men om alt skal sikres 100% blir det vanskelig å gjennomføre noe som helst.

[Iacob Mathiesen @iacob66]

@Prebens Mer fokus på og aksept for diagnose og behandling hjemme, muliggjort med ny teknologi/behandlings løsninger

[Iacob Mathiesen @iacob66]

#DNHelsetech Otivio og Stine presenterer FlowOx

[Iacob Mathiesen @iacob66]

Inovio's DNA-Encoded Monoclonal Antibody (dMAb(TM)) Platform Leaps Forward with First-in-Human Trial https://t.co/LlVnYtwgg6 via @YahooFinance

[Oakham School @OakhamSch]

Congratulations to Oakhamian and talented footballer Jenny who has been selected to join the national squad! Read more > https://t.co/QbAjTwbpyR ⚽️ @isfafootball @SpedeNews @rutland_radio

[Jeremy Crane @JeremyCraneMD]

@iacob66 @ProfChrisNester @StevenHaken An exciting technology for patients with peripheral vascular disease and chronic lower limb ulceration. @VascularNews @TheWoundClinic

[Iacob Mathiesen @iacob66]

FlowOx - FTI-H2020- consortium Meeting, FlowOx2.0 will soon be available for your patients! @JeremyCraneMD @ProfChrisNester @StevenHaken

[Punit Dhillon @PunitDhillon]

#ICYMI Our poster presentation of ImmunoPulse IL-12 and #pembrolizumab in patients predicted not to respond to anti-PD-1 alone $ONCS https://t.co/TlxNEsQOQe

[Iacob Mathiesen @iacob66]

@flowaid Thanks! :-)

[Dan Parker @DrDanParker]

Dr @FarinaHashmi presenting our Lower Limb Ischaemic FlowOx Treatment clinical trial | https://t.co/stiPUjcR8b
@HSRC_Research

[Fretta @OsloBizMemo]

Helse-oppstart #medtech best i Europa: #oslofirma sikret 30 #millioner #kroner @forskningsradet @OsloMedtech https://t.co/bogNsxgvx3

[David G. Armstrong follow @dgarmstrong.bsky.social @DGArmstrong]

New England Journal of Medicine: Diabetic Foot Ulcers and their Recurrence https://t.co/cIZkzWspqY

[Iacob Mathiesen @iacob66]

https://t.co/pv9q1CYTYQ

Salford research being presented!

[Iacob Mathiesen @iacob66]

FlowOx™ is improving blood flow in patients with peripheral arterial disease! https://t.co/FOHq1I5FHi

[Iacob Mathiesen @iacob66]

https://t.co/BC9PiTUCse

[INOVIO Pharmaceuticals @InovioPharma]

Inovio & Regeneron enter immuno-oncology clinical study agreement for Glioblastoma combination therapy $INO https://t.co/DgbQDPS5qQ